Boothbay Fund Management’s Connect Biopharma Holdings CNTB Stock Holding History
Bought
Maintained
Sold
Other funds holding CNTB
BCM
DMKJ
Boothbay Fund Management's CNTB Position: Q3 2026 in Review
Boothbay Fund Management reduced its Connect Biopharma Holdings (CNTB) stake by 59% in Q3 2026, selling an estimated $1.17M and leaving 402,059 shares worth $442K. The position accounts for 0.01% of the portfolio, ranked #1414.
Boothbay Fund Management first reported a position in CNTB in Q4 2021 and has held it in 11 quarters since. The position peaked at $3.48M in Q4 2025. 62 funds tracked by Wall St. Rank hold CNTB as of Q3 2026.
- Boothbay Fund Management held 402,059 shares of Connect Biopharma Holdings worth $442K as of Q3 2026.
- Boothbay Fund Management sold 571,673 Connect Biopharma Holdings shares in Q3 2026, an estimated $1.17M.
- Connect Biopharma Holdings made up 0.01% of Boothbay Fund Management's portfolio in Q3 2026, its #1414 holding.
- Boothbay Fund Management first reported a position in Connect Biopharma Holdings in Q4 2021 and has held it in 11 quarters since.
- Boothbay Fund Management's Connect Biopharma Holdings position peaked at $3.48M in Q4 2025.
- 62 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q3 2026.
Based on Boothbay Fund Management's 13F filing for Q3 2026, filed 16 Nov 2026.